An interventional study of Long Abstract and Short Abstract in Researchers Attention, sponsored by University of Oldenburg. Completed at 1 site in Germany. Per ClinicalTrials.gov, last updated 2024-11-08.
Sponsored by University of Oldenburg · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The present randomized controlled trial (RCT) was designed to investigate the perceptions of researchers on systematic review (SR) abstracts. The primary objective will be to compare readers' attention of shorter versus longer abstracts. The secondary objective will be to assess the perception of an abstract based on four indicators of a well-written abstract: (a) Informativeness, (b) Accuracy, (c) Attractiveness, and (d) Conciseness.
The study will involve researchers from all over the world who recently published an SR, regardless of their research field. To identify eligible authors, a search of MEDLINE (via PubMed) was conducted on May 5, 2024, for systematic reviews published between January 1, 2024, and March 26, 2024. A total of at least 6200 SRs will be selected from PubMed and assessed for eligibility. The corresponding author information will be extracted from all included SRs and randomized in a 1:1 ratio.
This study will attempt to emulate the reading process observed in PubMed. When searching PubMed, researchers are initially presented with an overview of the references identified. After clicking on the title, the corresponding abstract appears. For full-text access, researchers must actively follow a separate link to the journal page.
In this RCT, participants will be randomly assigned in a 1:1 ratio to two groups (those receiving a long abstract vs. those receiving a short abstract). Both groups receive the same cover letter by e-mail explaining the purpose of the study, the use of the data, measures to ensure anonymity of participation, and a link for participation.
The link will direct participants to SoSci Survey, an online survey tool. Those in the group receiving the long abstract will see an abstract with a length of 771 words (PMID: 37955353). Those in the group receiving the short abstract will see an abstract with a length of 277 words (PMID: 37942649). Both abstracts are structured and pertain to the same review entitled "Percutaneous nephrolithotomy vs. retrograde intrarenal surgery for renal stones". This review was published once in the Cochrane Database of Systematic Reviews and once in the journal BJU International.
The design of the abstract presented is similar to that of PubMed, but no title or authors will be indicated. After reading the abstract, participants must actively click the "Continue" button to proceed with the survey.
University of Oldenburg is the lead sponsor of 6 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
The corresponding authors of systematic reviews that were indexed in PubMed between January 1, 2024, and March 26, 2024, and for which an English abstract is available will be included. These include authors of all types of SR, with the majority likely representing SRs on effectiveness. Authors of other types of evidence syntheses (e.g. scoping reviews, methodological papers), editorials, protocols, corrections, retractions, erratums, or summaries of SRs will be excluded.
For identifying the systematic reviews from which the corresponding authors will be contacted we will use the following eligibility criteria.
Inclusion Criteria:
Exclusion Criteria:
Abstract length: 771 words
Other: Long Abstract
Abstract length: 277 words
Other: Short Abstract
The intervention and control group will be provided with a structured abstract of the review by Soderberg et al., entitled "Percutaneous nephrolithotomy vs. retrograde intrarenal surgery for renal stones". This review was published once in the Cochrane Database of Systematic Reviews and once in the journal BJU International. The length of the abstract differs significantly depending on the journal. The participants assigned to this study arm will be presented with the longer version published in the Cochrane Database, comprising 771 words (PMID: 37955353).
The participants assigned to this study arm will be presented with the shorter version published in BJU International, comprising 277 words (PMID: 37942649).
Trial participation
The primary outcome of this RCT will be the trial participation, which is defined as the proportion of participants who read the abstract and then clicked on the "Continue" button. This will be quantified by dividing the number of participants who read the abstract and proceeded to complete the survey by the total number of individuals who clicked on the link in the email. Information will be electronically captured in SoSci survey.
Time frame: Immediately after reading the abstract
Indicators of a well-written abstract
The secondary outcomes will be four indicators of a well-written abstract, as follows: 1. Informativeness 2. Accuracy 3. Attractiveness 4. Conciseness. The extent to which participants perceive these criteria to be fulfilled will be quantified on a 4-point Likert scale, e.g. very little informative, little informative, informative, very informative. For data analysis, the data will be dichotomized. For instance, the statements "very little informative" and "little informative" will be summarized in the category "non-informative," while the statements "informative" and "very informative" will be summarized in the category "informative."
Time frame: Immediately after reading the abstract
Time needed to read the abstract
The time needed to read the abstract will be quantified. The time interval is defined as the period between the participant clicking on the link in the email and clicking on the "Continue" button to proceed to the survey. This time will be automatically recorded by SoSci Survey.
Time frame: Immediately after reading the abstract
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Aug 2024 to primary completion in Sep 2024, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Oldenburg